Bill Sponsor
New York Assembly Bill 265
Session 2025-2026
Relates to the availability of opioid reversal agents
Active
Active
Passed Assembly on Jun 13, 2025
Sponsor
First Action
Jan 8, 2025
Latest Action
Jun 13, 2025
Origin Chamber
Assembly
Type
Bill
Bill Number
265
State
New York
Session
2025-2026
Sponsorship by Party
Democrat
Primary
Democrat
Cosponsor
Democrat
Cosponsor
Democrat
Cosponsor
Democrat
Cosponsor
Republican
Cosponsor
Democrat
Cosponsor
Republican
Cosponsor
Democrat
Cosponsor
Republican
Cosponsor
Democrat
Cosponsor
Assembly Votes (1)
checkPassed on June 13, 2025
Motion Text
Assembly Vote
Assembly Roll Call Votes
Excused
Excused
Unknown
Bailey
Yes
Unknown
Jackson
Yes
Unknown
Mr. Speaker
Excused
Unknown
Ramos
Yes
Unknown
Rivera
Yes
Excused
Summary
Relates to the availability of opioid reversal agents; requires the department of health to make available any formulation and dosage of opioid reversal agent approved by the federal food and drug administration.
Actions (10)
06/13/2025
Assembly
DELIVERED TO SENATE
06/13/2025
Assembly
PASSED ASSEMBLY
06/13/2025
Assembly
ORDERED TO THIRD READING RULES CAL.705
06/13/2025
Assembly
RULES REPORT CAL.705
06/13/2025
Assembly
REPORTED
06/13/2025
Assembly
REPORTED REFERRED TO RULES
02/11/2025
Assembly
REPORTED REFERRED TO WAYS AND MEANS
01/10/2025
Assembly
PRINT NUMBER 265A
01/10/2025
Assembly
AMEND AND RECOMMIT TO ALCOHOLISM AND DRUG ABUSE
01/08/2025
Assembly
REFERRED TO ALCOHOLISM AND DRUG ABUSE